This is so so true

25 Posts Not To Miss From ELCC 2024
oncodaily.com/41993.html
Dr. Antonio Calles 🫁🚭 Giannis Mountzios Stephen V Liu, MD Julien Mazieres Alfredo Addeo MD Jennifer C. King, PhD Eric K. Singhi, MD Mariana Brandao Charu Aggarwal, MD, MPH, FASCO Gerry Hanna Xiuning Le MD PhD Alona Zer giuseppe viscardi Noemi Reguart Jarushka Naidoo Cecilia Pompili MD PhD FACS #OncoDaily

#ELCC24 poster addressing the role of pCR as predictor of EFS benefit for immunotp in early NSCLC, and comparing periop and neoad according to PD-L1 and pCR. Kudos to Antonio Nuccio presenting our work!

Great news from Prague ESMO - Eur. Oncology #ELCC24 ! Our work led by Roberto Ferrara on waning effect of EGFR TKIs in adjuvant setting won best poster award! Mario Occhipinti Martina Imbimbo Vittorio Simeon

Best post award for waning effect of adjuvant EGFR TKIs in resected NSCLC. Cochrane Metanalysis Lung Cancer Group. The Cochrane Library Cochrane Mario Occhipinti Martina Imbimbo Vittorio Simeon giuseppe viscardi
#ELCC24

pieces of knowledge about immunotherapy in early NSCLC Roberto Ferrara Antonio Nuccio Marina Garassino valter torri

a meta-analysis exploring the role of clinicopathological variables ejcancer.com/article/S0959-…

MPR and pCR as surrogate endpoints for EFS jto.org/article/S1556-…

It' s not all about pCR. MPR showed good surrogacy score with 2 years EFS (same as pCR) giuseppe viscardi Antonio Nuccio.
Great work led by Valter Torri and Marina Garassino Tina Cascone
JTO & JTO CRR

For those practicing in countries where 1st line single agent IO can't be prescribed in NSCLC <50%
How confident are you in delivering triplet therapy (chemo-IO) in frail/elderly pts? Do you use modified regimens (e.g. reduced chemo-dose upfront) with ease? Giuseppe Banna Alfredo Addeo MD

❗follow this newborn project
Apollo 11, an Italian network of thoracic oncologists aiming to integrate RWD, translational research and AI 🫁🧪🩺💻 clinical-lung-cancer.com/article/S1525-…

New study uncovers that ≈ a third of NSCLC patients develop specific mutations as acquired resistance to #immunotherapy , including alterations in STK11, B2M, APC,MTOR, KEAP1, & JAK1/2. ascopubs.org/doi/10.1200/JC…

Se la #Costituzione tutela il diritto alla #salute di TUTTI, la #sanità deve essere per TUTTI

Mandiamo in tendenza #SalviamoSSN
RT 🙏

❗️Out now on Frontiers - Immunology
➡️retrospective multicenter data support consolidative thoracic radiotherapy in patients with E-SCLC in the era of frontline chemo-immunotherapy
frontiersin.org/articles/10.33…

'Statisticians should embrace AI, and in response, the field of AI will benefit from increased statistical thinking.' nejm.org/doi/full/10.10…

New Research: Consolidative thoracic radiation therapy for extensive-stage small cell lung cancer in the era of first-line chemoimmunotherapy: preclinical data and a retrospective study in Southern Italy: Background

Consolidative thoracic… frontiersin.org/articles/10.33… #immunology

cancer cells - neurons synaptic interaction: a new (druggable) mechanism promoting malignancy dissemination?
biorxiv.org/content/10.110…

Lung cancer in patients who never smoked -an emerging disease

“The global incidence of lung cancer decreasing in parallel w/ declining smoking rates in developed countries- the incidence of LC in individuals who have never smoked is stable or increasing”

nature.com/articles/s4157…

Liquid Biopsy Response Evaluation Criteria in Solid Tumors (LB-RECIST) - Annals of Oncology annalsofoncology.org/article/S0923-…

Abstracts wanted! Showcase your work in AI for oncology and research by presenting an abstract for the 2nd edition of the AI for Oncology conference, held at Istituto Tumori on 10th May 2024- tinyurl.com/y5x3n4mj Register to the event: events-communication.com/event/ai2024/ #ClinicalAI #AI4Onc24

🎓 Annunciazione annunciazione!

La prossima edizione del nostro Master in #Statistica per la #RicercaClinica e #Epidemiologia è in arrivo! 🚀

Diffondi la voce ed entra in contatto con noi!

🌐 Resta aggiornato per il bando ufficiale.

#Master2023 #FormazioneAccademica

Rethinking health care in a changing wolrd